Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5925 | 1487 | 39.0 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
81 | 26583 | MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MLL | Author keyword | 144 | 55% | 12% | 179 |
2 | MLL GENE | Author keyword | 68 | 80% | 3% | 43 |
3 | 11Q23 | Author keyword | 35 | 61% | 2% | 37 |
4 | INFANT LEUKEMIA | Author keyword | 22 | 53% | 2% | 30 |
5 | CALM AF10 | Author keyword | 18 | 83% | 1% | 10 |
6 | T411 | Author keyword | 18 | 83% | 1% | 10 |
7 | DIAGNOST ACUTE LEUKEMIA | Address | 17 | 72% | 1% | 13 |
8 | INFANT ACUTE LYMPHOBLASTIC LEUKEMIA | Author keyword | 15 | 82% | 1% | 9 |
9 | 11Q23 TRANSLOCATIONS | Author keyword | 15 | 88% | 0% | 7 |
10 | HRX | Author keyword | 15 | 88% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MLL | 144 | 55% | 12% | 179 | Search MLL | Search MLL |
2 | MLL GENE | 68 | 80% | 3% | 43 | Search MLL+GENE | Search MLL+GENE |
3 | 11Q23 | 35 | 61% | 2% | 37 | Search 11Q23 | Search 11Q23 |
4 | INFANT LEUKEMIA | 22 | 53% | 2% | 30 | Search INFANT+LEUKEMIA | Search INFANT+LEUKEMIA |
5 | CALM AF10 | 18 | 83% | 1% | 10 | Search CALM+AF10 | Search CALM+AF10 |
6 | T411 | 18 | 83% | 1% | 10 | Search T411 | Search T411 |
7 | INFANT ACUTE LYMPHOBLASTIC LEUKEMIA | 15 | 82% | 1% | 9 | Search INFANT+ACUTE+LYMPHOBLASTIC+LEUKEMIA | Search INFANT+ACUTE+LYMPHOBLASTIC+LEUKEMIA |
8 | 11Q23 TRANSLOCATIONS | 15 | 88% | 0% | 7 | Search 11Q23+TRANSLOCATIONS | Search 11Q23+TRANSLOCATIONS |
9 | HRX | 15 | 88% | 0% | 7 | Search HRX | Search HRX |
10 | T1011 | 15 | 88% | 0% | 7 | Search T1011 | Search T1011 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DROSOPHILA TRITHORAX | 262 | 61% | 19% | 279 |
2 | 11Q23 TRANSLOCATIONS | 169 | 80% | 7% | 106 |
3 | ALL 1 GENE | 167 | 76% | 8% | 118 |
4 | 11Q23 CHROMOSOMAL TRANSLOCATIONS | 149 | 81% | 6% | 91 |
5 | T10 11 TRANSLOCATION | 111 | 88% | 3% | 52 |
6 | MLL GENE | 101 | 51% | 10% | 142 |
7 | 11Q23 | 89 | 57% | 7% | 106 |
8 | HRX ENL | 87 | 86% | 3% | 44 |
9 | PROTO ONCOPROTEIN MLL | 85 | 92% | 2% | 34 |
10 | T4 11Q21 Q23 | 46 | 82% | 2% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins | 2001 | 308 | 94 | 61% |
MLL translocations, histone modifications and leukaemia stem-cell development | 2007 | 391 | 115 | 56% |
The Pathogenesis of Mixed-Lineage Leukemia | 2012 | 67 | 106 | 68% |
The molecular biology of mixed lineage leukemia | 2009 | 117 | 116 | 69% |
Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L | 2015 | 2 | 17 | 71% |
MLL: a histone methyltransferase disrupted in leukemia | 2004 | 177 | 63 | 65% |
MLL rearrangements in haematological malignancies: Lessons from clinical and biological studies | 1999 | 160 | 86 | 76% |
Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis | 2004 | 102 | 74 | 70% |
Biological and therapeutic aspects of infant leukemia | 2000 | 187 | 149 | 52% |
In focus: MLL-rearranged leukemia | 2013 | 22 | 78 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIAGNOST ACUTE LEUKEMIA | 17 | 72% | 0.9% | 13 |
2 | DCAL | 11 | 57% | 0.9% | 13 |
3 | LEONARD MADLYN ABRAMSON PEDIAT | 5 | 60% | 0.4% | 6 |
4 | INTERFANT TRIAL DATA | 4 | 75% | 0.2% | 3 |
5 | PHARMACEUT BIOL ZAFES | 4 | 75% | 0.2% | 3 |
6 | ZAFESBIO | 4 | 75% | 0.2% | 3 |
7 | JEFFERSON MED MICROBIOL IMMUNOL | 3 | 60% | 0.2% | 3 |
8 | ABT INNERE MED A | 2 | 67% | 0.1% | 2 |
9 | ALL BFM TRIAL | 2 | 67% | 0.1% | 2 |
10 | MED CELL TECHNOL | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232048 | NUP98//T711P15P15//DDX10 |
2 | 0.0000178276 | TEL AML1//LEUKAEMIA CYTOGENET GRP//ETV6 |
3 | 0.0000127767 | TETRASOMY 8//NEAR TETRAPLOIDY//TRISOMY 4 |
4 | 0.0000101932 | LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL |
5 | 0.0000090534 | SECONDARY LEUKEMIA//SECOND MALIGNANT NEOPLASM//THERAPY RELATED |
6 | 0.0000078372 | TRANSIENT MYELOPROLIFERATIVE DISORDER//TRANSIENT LEUKEMIA//TRANSIENT ABNORMAL MYELOPOIESIS |
7 | 0.0000077956 | FLT3//FLT3 ITD//NPM1 |
8 | 0.0000076880 | HEMATOGONES//BIPHENOTYPIC ACUTE LEUKEMIA//IMMUNOPHENOTYPING |
9 | 0.0000076876 | SEPTIN//SEPTINS//SEPT9 |
10 | 0.0000073909 | RUNX3//AML1 ETO//AML1 |